Women do not suffer cognitive loss when taking hormone replacement therapy to treat symptoms of menopause, a new study finds. Researchers tested the treatment for six months in early postmenopausal women between the ages of 49 and 55 who had never used HRT E2D—a combination of hormones estradiol and drospirenone. The examined HRT’s effects on memory, language and concentration.